机构

• 上海药物研究所 [45]

采集方式

• OAI收割 [45]

内容类型

• 期刊论文 [45]

发表日期

• 2023 [7]
• 2022 [7]
• 2019 [3]
• 2018 [4]
• 2017 [6]
• 2016 [5]
• 更多

学科主题

筛选

浏览/检索结果: 共45条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Inhibiting Endothelial Cell-Mediated T Lymphocyte Apoptosis with Integrin-Targeting Peptide-Drug Conjugate Filaments for Chemoimmunotherapy of Triple-Negative Breast Cancer 期刊论文  OAI收割 ADVANCED MATERIALS, 2023, 页码: 12 作者:  Cai, Ying;  Zhu, Binyu;  Shan, Xiaoting;  Zhou, Lingli;  Sun, Xujie   |  收藏  |  浏览/下载：23/0  |  提交时间：2024/01/16 Fas ligand  immunotherapy  peptide-drug conjugate  triple-negative breast cancer  tumor-associated endothelial cells   Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 259, 页码: 19 作者:  Wang, Pingyuan;  Zhu, Wen-Ting;  Wang, Yajing;  Song, Shan-Shan;  Xi, Yong   |  收藏  |  浏览/下载：58/0  |  提交时间：2023/10/17 PARP1 inhibitor  Synthetic lethality  Drug resistance  Anticancer  Structure -activity relationship   STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy 期刊论文  OAI收割 NATIONAL SCIENCE REVIEW, 2023, 卷号: 10, 期号: 10, 页码: 16 作者:  Zhou, Lei;  Yi, Wenzhe;  Zhang, Zehong;  Shan, Xiaoting;  Zhao, Zitong   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/10/17 vaccine  mRNA  STING  cancer immunotherapy  nanoparticles   Identification of lignans as ATP citrate lyase (ACLY) inhibitors from the roots of Pouzolzia zeylanica 期刊论文  OAI收割 NATURAL PRODUCT RESEARCH, 2023, 页码: 8 作者:  Li, Jin-Long;  Jiang, Jia-Yi;  Gu, Shan-Shan;  Zhang, Lei;  Sun, Yan   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/10/17 Pouzolzia zeylanica  lignans  ATP citrate lyase (ACLY) inhibitors   PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1 期刊论文  OAI收割 MedComm, 2023, 卷号: 4, 期号: 2, 页码: e245 作者:  Xie, Fei;  Zhang, Han;  Zhu, Kongkai;  Jiang, Cheng-Shi;  Zhang, Xiaoya   |  收藏  |  浏览/下载：12/0  |  提交时间：2024/03/26 Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance 期刊论文  OAI收割 EMBO MOLECULAR MEDICINE, 2023, 页码: 24 作者:  Wang, Li-Min;  Wang, Pingyuan;  Chen, Xiao-Min;  Yang, Hui   |  收藏  |  浏览/下载：21/0  |  提交时间：2023/04/10 homologous recombination repair  olaparib-resistant  PARP inhibitor  PARP7  type I interferons   PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 1, 页码: 157-173 作者:  Sun, Mingming;  Li, Leilei;  Niu, Yujia;  Wang, Yingzhi;  Yan, Qi   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/03/27 Lung cancer  Metabolic reprogramming  Post-translational modification  PRMT6  Pentose phosphate pathway flux  Glycolysis  6-Phospho-gluconate dehydrogenase  a-enolase  ENO1   Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia 期刊论文  OAI收割 CELL RESEARCH, 2022, 页码: 19 作者:  Hu, Cheng-Long;  Chen, Bing-Yi;  Li, Zijuan;  Yang, Tianbiao;  Xu, Chun-Hui   |  收藏  |  浏览/下载：30/0  |  提交时间：2022/12/13 PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way 期刊论文  OAI收割 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 10, 页码: 15 作者:  Yu, Xiaolu;  Long, Yiru;  Chen, Binfan;  Tong, Yongliang;  Shan, Mengwen   |  收藏  |  浏览/下载：36/0  |  提交时间：2022/12/13 PD-L1  TLR7  nanobody-drug-conjugate  cancer immunotherapy   Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV-2 papain-like protease 期刊论文  OAI收割 ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 卷号: 54, 期号: 8, 页码: 1133-1139 作者:  Zou, Zhihui;  Shan, Huizhuang;  Sun, Demeng;  Xia, Li;  Shi, Yulong   |  收藏  |  浏览/下载：33/0  |  提交时间：2022/11/11 COVID-19  SARS-CoV-2  PLpro  Parthenolide  deISGylation